rspНаучно-практическая ревматологияRheumatology Science and Practice1995-44841995-4492IMA-PRESS, LLC10.47360/1995-4484-2025-348-356rsp-3781Research ArticleОБЗОРЫ И ЛЕКЦИИREVIEWS AND LECTURESБолезнь Шёгрена: мифы и реальность. Часть IMyths and reality. Part I.https://orcid.org/0000-0003-4188-3578ЧальцевБ. Д.ChaltsevB. D.

Чальцев Богдан Дмитриевич

115522, Москва, Каширское шоссе, 34а

Bogdan D. Chaltsev

115522, Moscow, Kashirskoye Highway 34A

https://orcid.org/0000-0002-1425-8622ВасильевВ. И.VasilyevV. I.

107140, Москва, ул. Нижняя Красносельская, 4

Vladimir I. Vasilyev

107140, Moscow, Nizhnyaya Krasnoselskaya str., 4

https://orcid.org/0000-0001-8099-2107ТоргашинаА. В.TorgashinaA. V.

115522, Москва, Каширское шоссе, 34а

Anna V. Torgashina

115522, Moscow, Kashirskoye Highway 34A

ФГБНУ «Научно-исследовательский институт ревматологии им. В.А. Насоновой»РоссияV.A. Nasonova Research Institute of RheumatologyRussian FederationООО «Ревмоцентр»Россия“Revmotsentr” LLCRussian Federation202531082025634348356Copyright © Чальцев Б.Д., Васильев В.И., Торгашина А.В., 20252025Чальцев Б.Д., Васильев В.И., Торгашина А.В.Chaltsev B.D., Vasilyev V.I., Torgashina A.V.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://rsp.mediar-press.net/rsp/article/view/3781

Стоматологические и офтальмологические проявления болезни Шёгрена (БШ) впервые описаны более 100 лет назад, а в качестве самостоятельной нозологической единицы БШ получила признание в 1965 году. Тем не менее, в настоящее время диагностика и лечение данного заболевания по-прежнему вызывают существенные затруднения в связи с низкой осведомленностью врачей об особенностях течения болезни. В первой части статьи приведены наиболее распространенные и значимые мифы об эпидемиологии и диагностике БШ.

Oral and ocular manifestations of Sjögren’s disease (SjD) were first described over 100 years ago, but SjD was recognized as an independent nosology in 1965. However, currently the diagnosis and treatment of this disease still pose significant difficulties due to low awareness of physicians about the characteristics of the disease. The first part of the article presents the most common and significant myths in epidemiology and diagnostics of SjD.

болезнь Шёгренасиндром Шёгренаболезнь Шёгрена с ювенильным началомMALTлимфомаSjogren’s diseaseSjogren’s syndromejuvenile Sjogren’s diseaseMALT lymphomaСтатья подготовлена в рамках фундаментальной темы (регистрационный № 1021051402790-6)ReferencesSisó-Almirall A, Kostov B, Martínez-Carbonell E, Brito-Zerón P, Ramirez PB, Acar-Denizli N, et al. The prevalence of 78 autoimmune diseases in Catalonia (MASCAT-PADRIS Big Data Project). Autoimmun Rev. 2020;19(2):102448. doi: 10.1016/j.autrev.2019.102448Sisó-Almirall A, Kostov B, Martínez-Carbonell E, Brito-Zerón P, Ramirez PB, Acar-Denizli N, et al. The prevalence of 78 autoimmune diseases in Catalonia (MASCAT-PADRIS Big Data Project). Autoimmun Rev. 2020;19(2):102448. doi: 10.1016/j.autrev.2019.102448Qin B, Wang J, Yang Z, Yang M, Ma N, Huang F, et al. Epidemiology of primary Sjögren’s syndrome: A systematic review and meta-analysis. Ann Rheum Dis. 2015;74(11):1983-1989. doi: 10.1136/annrheumdis-2014-205375Qin B, Wang J, Yang Z, Yang M, Ma N, Huang F, et al. Epidemiology of primary Sjögren’s syndrome: A systematic review and meta-analysis. Ann Rheum Dis. 2015;74(11):1983-1989. doi: 10.1136/annrheumdis-2014-205375Vivino FB, Bunya VY, Massaro-Giordano G, Johr CR, Giattino SL, Schorpion A, et al. Sjogren’s syndrome: An update on disease pathogenesis, clinical manifestations and treatment. Clin Immunol. 2019;203:81-121. doi: 10.1016/j.clim.2019.04.009Vivino FB, Bunya VY, Massaro-Giordano G, Johr CR, Giattino SL, Schorpion A, et al. Sjogren’s syndrome: An update on disease pathogenesis, clinical manifestations and treatment. Clin Immunol. 2019;203:81-121. doi: 10.1016/j.clim.2019.04.009Helmick CG, Felson DT, Lawrence RC, Gabriel S, Hirsch R, Kwoh CK, et al.; National Arthritis Data Workgroup. Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part I. Arthritis Rheum. 2008;58(1):15-25. doi: 10.1002/art.23177Helmick CG, Felson DT, Lawrence RC, Gabriel S, Hirsch R, Kwoh CK, et al.; National Arthritis Data Workgroup. Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part I. Arthritis Rheum. 2008;58(1):15-25. doi: 10.1002/art.23177Brito-Zerón P, Retamozo S, Ramos-Casals M. Phenotyping Sjögren’s syndrome: Towards a personalised management of the disease. Clin Exp Rheumatol. 2018;36 Suppl 112(3):198-209.Brito-Zerón P, Retamozo S, Ramos-Casals M. Phenotyping Sjögren’s syndrome: Towards a personalised management of the disease. Clin Exp Rheumatol. 2018;36 Suppl 112(3):198-209.Mathews PM, Robinson SA, Gire A, Baer AN, Akpek EK. Extrag-landular ocular involvement and morbidity and mortality in primary Sjögren’s syndrome. PLoS One. 2020;15(9):e0239769. doi: 10.1371/journal.pone.0239769Mathews PM, Robinson SA, Gire A, Baer AN, Akpek EK. Extrag-landular ocular involvement and morbidity and mortality in primary Sjögren’s syndrome. PLoS One. 2020;15(9):e0239769. doi: 10.1371/journal.pone.0239769Сафонова ТН, Васильев ВИ, Лихванцева ВГ. Синдром Шёгрена: Руководство для врачей. М.:Издательство Московского государственного университета;2013.Safonova TN, Vasiliev VI, Likhvantseva VG. Sjögren’s syndrome: A guide for physicians. Moscow:Publishing House of Moscow State University;2013 (In Russ.).Brito-Zerón P, Acar-Denizli N, Ng WF, Zeher M, Rasmussen A, Mandl T, et al.; Sjögren Big Data Consortium. How immunological profile drives clinical phenotype of primary Sjögren’s syndrome at diagnosis: analysis of 10,500 patients (Sjögren Big Data Project). Clin Exp Rheumatol. 2018;36 Suppl 112(3):102-112.Brito-Zerón P, Acar-Denizli N, Ng WF, Zeher M, Rasmussen A, Mandl T, et al.; Sjögren Big Data Consortium. How immunological profile drives clinical phenotype of primary Sjögren’s syndrome at diagnosis: analysis of 10,500 patients (Sjögren Big Data Project). Clin Exp Rheumatol. 2018;36 Suppl 112(3):102-112.Ramos-Casals M, Acar-Denizli N, Vissink A, Brito-Zerón P, Li X, Carubbi F, et al.; Sjogren Big Data Consortium. Childhoodonset of primary Sjögren’s syndrome: Phenotypic characterization at diagnosis of 158 children. Rheumatology (Oxford). 2021;60(10):4558-4567. doi: 10.1093/rheumatology/keab032Ramos-Casals M, Acar-Denizli N, Vissink A, Brito-Zerón P, Li X, Carubbi F, et al.; Sjogren Big Data Consortium. Childhoodonset of primary Sjögren’s syndrome: Phenotypic characterization at diagnosis of 158 children. Rheumatology (Oxford). 2021;60(10):4558-4567. doi: 10.1093/rheumatology/keab032Shiboski CH, Shiboski SC, Seror R, Criswell LA, Labetoulle M, Lietman TM, et al.; International Sjögren’s Syndrome Criteria Working Group. 2016 American College of Rheumatology/European League Against Rheumatism classification criteria for primary Sjögren’s syndrome: A consensus and data-driven methodology involving three international patient cohorts. Arthritis Rheumatol. 2017;69(1):35-45. doi: 10.1002/art.39859Shiboski CH, Shiboski SC, Seror R, Criswell LA, Labetoulle M, Lietman TM, et al.; International Sjögren’s Syndrome Criteria Working Group. 2016 American College of Rheumatology/European League Against Rheumatism classification criteria for primary Sjögren’s syndrome: A consensus and data-driven methodology involving three international patient cohorts. Arthritis Rheumatol. 2017;69(1):35-45. doi: 10.1002/art.39859Takagi Y, Hashimoto K, Sasaki M, Eida S, Katayama I, Sumi M. Juvenile onset of primary Sjögren’s syndrome: Changes in imaging findings during a 7-year progression. Clin Exp Rheumatol. 2022;40(12):2466-2467. doi: 10.55563/clinexprheumatol/z3exkqTakagi Y, Hashimoto K, Sasaki M, Eida S, Katayama I, Sumi M. Juvenile onset of primary Sjögren’s syndrome: Changes in imaging findings during a 7-year progression. Clin Exp Rheumatol. 2022;40(12):2466-2467. doi: 10.55563/clinexprheumatol/z3exkqTomiita M, Saito K, Kohno Y, Shimojo N, Fujikawa S, Niimi H. The clinical features of Sjögren’s syndrome in Japanese children. Acta Paediatr Jpn. 1997;39(2):268-272. doi: 10.1111/j.1442-200x.1997.tb03597.xTomiita M, Saito K, Kohno Y, Shimojo N, Fujikawa S, Niimi H. The clinical features of Sjögren’s syndrome in Japanese children. Acta Paediatr Jpn. 1997;39(2):268-272. doi: 10.1111/j.1442-200x.1997.tb03597.xHoughton K, Malleson P, Cabral D, Petty R, Tucker L. Primary Sjögren’s syndrome in children and adolescents: Are proposed diagnostic criteria applicable? J Rheumatol. 2005;32(11):2225-2232.Houghton K, Malleson P, Cabral D, Petty R, Tucker L. Primary Sjögren’s syndrome in children and adolescents: Are proposed diagnostic criteria applicable? J Rheumatol. 2005;32(11):2225-2232.Vasiliev V, Gaiduk I, Palshina S, Shornikova N, Shornikova L. Lymphomas in patients with juvenile-onset primary Sjogren’s syndrome. Int J Rheum Dis. 2024;27:e15346. doi: 10.1111/1756-185X.15346Vasiliev V, Gaiduk I, Palshina S, Shornikova N, Shornikova L. Lymphomas in patients with juvenile-onset primary Sjogren’s syndrome. Int J Rheum Dis. 2024;27:e15346. doi: 10.1111/1756-185X.15346Chen J, He Q, Yang J, Wu T, Huang Z, Zhang Y, et al. Anti-SSA/SSB-negative primary Sjögren’s syndrome showing different clinical phenotypes: A retrospective study of 934 cases. Adv Rheumatol. 2023;63(1):21. doi: 10.1186/s42358-023-00304-4Chen J, He Q, Yang J, Wu T, Huang Z, Zhang Y, et al. Anti-SSA/SSB-negative primary Sjögren’s syndrome showing different clinical phenotypes: A retrospective study of 934 cases. Adv Rheumatol. 2023;63(1):21. doi: 10.1186/s42358-023-00304-4Грачева ВГ, Васильев ВИ, Симонова МВ, Сафонова ТН, Иванова СМ, и др. Клинико-лабораторная характеристика больных болезнью Шегрена с началом заболевания в молодом возрасте. Терапевтический архив. 1998;70(5):55-58.Gracheva VG, Vasiliev VI, Simonova MV, Safonova TN, Ivanova SM, et al. Clinical and laboratory characteristics of patients with Sjogren’s disease lasting from young age. Terapevticheskii arkhiv. 1998;70(5):55-58 (In Russ.).Чальцев БД, Васильев ВИ, Пальшина СГ, Торгашина АВ, Сокол ЕВ, Хван ЮИ, и др. Сравнительная характеристика клинико-лабораторных особенностей болезни Шегрена с антицентромерными антителами и «классического» субтипа заболевания. Научно-практическая ревматология. 2021;59(2):158-163. doi: 10.47360/1995-4484-2021-158-163Chaltsev BD, Vasiliev VI, Palshina SG, Torgashina AV, Sokol EV, Khvan YuI, et al. Comparative characteristics of the clinical and laboratory features of the primary Sjogren’s syndrome associated with anticentromere antibodies and the “classic” subtype of the disease. Nauchno-Prakticheskaya Revmatologia = Rheumatology Science and Practice. 2021;59(2):158-163 (In Russ.). doi: 10.47360/1995-4484-2021-158-163Vasiliev V, Palshina S, Gaiduc I, Probatova N., Gorodetskiy V, et al. Marginal zone lymphomas in primary and secondary Sjogren’s syndrome. Clinical and Experimental Rheumatology. 2022:41-42.Vasiliev V, Palshina S, Gaiduc I, Probatova N., Gorodetskiy V, et al. Marginal zone lymphomas in primary and secondary Sjogren’s syndrome. Clinical and Experimental Rheumatology. 2022:41-42.Насонов ЕЛ (ред.). Ревматология. Российские клинические рекомендации. М.:ГЭОТАР-Медиа;2017. [Nasonov EL (ed.). Rheumatology. Russian clinical recommendations. Moscow:GEOTAR-Media;2017 (In Russ.)].Насонов ЕЛ (ред.). Ревматология. Российские клинические рекомендации. М.:ГЭОТАР-Медиа;2017. [Nasonov EL (ed.). Rheumatology. Russian clinical recommendations. Moscow:GEOTAR-Media;2017 (In Russ.)].García-Carrasco M, Ramos-Casals M, Rosas J, Pallarés L, Calvo-Alen J, Cervera R, et al. Primary Sjögren syndrome: Clinical and immunologic disease patterns in a cohort of 400 patients. Medicine (Baltimore). 2002;81(4):270-280. doi: 10.1097/00005792-200207000-00003García-Carrasco M, Ramos-Casals M, Rosas J, Pallarés L, Calvo-Alen J, Cervera R, et al. Primary Sjögren syndrome: Clinical and immunologic disease patterns in a cohort of 400 patients. Medicine (Baltimore). 2002;81(4):270-280. doi: 10.1097/00005792-200207000-00003Shiboski SC, Shiboski CH, Criswell L, Baer A, Challacombe S, Lanfranchi H, et al.; Sjögren’s International Collaborative Clinical Alliance (SICCA) Research Groups. American College of Rheumatology classification criteria for Sjögren’s syndrome: A datadriven, expert consensus approach in the Sjögren’s International Collaborative Clinical Alliance cohort. Arthritis Care Res (Hoboken). 2012;64(4):475-487. doi: 10.1002/acr.21591Shiboski SC, Shiboski CH, Criswell L, Baer A, Challacombe S, Lanfranchi H, et al.; Sjögren’s International Collaborative Clinical Alliance (SICCA) Research Groups. American College of Rheumatology classification criteria for Sjögren’s syndrome: A datadriven, expert consensus approach in the Sjögren’s International Collaborative Clinical Alliance cohort. Arthritis Care Res (Hoboken). 2012;64(4):475-487. doi: 10.1002/acr.21591Retamozo S, Akasbi M, Brito-Zerón P, Bosch X, Bove A, Perezde-Lis M, et al. Anti-Ro52 antibody testing influences the classification and clinical characterisation of primary Sjögren’s syndrome. Clin Exp Rheumatol. 2012;30(5):686-692.Retamozo S, Akasbi M, Brito-Zerón P, Bosch X, Bove A, Perezde-Lis M, et al. Anti-Ro52 antibody testing influences the classification and clinical characterisation of primary Sjögren’s syndrome. Clin Exp Rheumatol. 2012;30(5):686-692.Decker P, Moulinet T, Pontille F, Cravat M, De Carvalho Bittencourt M, Jaussaud R. An updated review of anti-Ro52 (TRIM21) antibodies impact in connective tissue diseases clinical management. Autoimmun Rev. 2022;21(3):103013. doi: 10.1016/j.autrev.2021.103013Decker P, Moulinet T, Pontille F, Cravat M, De Carvalho Bittencourt M, Jaussaud R. An updated review of anti-Ro52 (TRIM21) antibodies impact in connective tissue diseases clinical management. Autoimmun Rev. 2022;21(3):103013. doi: 10.1016/j.autrev.2021.103013ter Borg EJ, Kelder JC. Lower prevalence of extra-glandular mani-festations and anti-SSB antibodies in patients with primary Sjögren’s syndrome and widespread pain: Evidence for a relatively benign subset. Clin Exp Rheumatol. 2014;32(3):349-353.ter Borg EJ, Kelder JC. Lower prevalence of extra-glandular mani-festations and anti-SSB antibodies in patients with primary Sjögren’s syndrome and widespread pain: Evidence for a relatively benign subset. Clin Exp Rheumatol. 2014;32(3):349-353.Nishikai M, Akiya K, Tojo T, Onoda N, Tani M, Shimizu K. ‘Seronegative’ Sjögren’s syndrome manifested as a subset of chronic fatigue syndrome. Br J Rheumatol. 1996;35(5):471-474. doi: 10.1093/rheumatology/35.5.471Nishikai M, Akiya K, Tojo T, Onoda N, Tani M, Shimizu K. ‘Seronegative’ Sjögren’s syndrome manifested as a subset of chronic fatigue syndrome. Br J Rheumatol. 1996;35(5):471-474. doi: 10.1093/rheumatology/35.5.471Segal BM, Pogatchnik B, Henn L, Rudser K, Sivils KM. Pain severity and neuropathic pain symptoms in primary Sjögren’s syndrome: A comparison study of seropositive and seronegative Sjögren’s syndrome patients. Arthritis Care Res (Hoboken). 2013;65(8):1291-1298. doi: 10.1002/acr.21956Segal BM, Pogatchnik B, Henn L, Rudser K, Sivils KM. Pain severity and neuropathic pain symptoms in primary Sjögren’s syndrome: A comparison study of seropositive and seronegative Sjögren’s syndrome patients. Arthritis Care Res (Hoboken). 2013;65(8):1291-1298. doi: 10.1002/acr.21956Quartuccio L, Baldini C, Bartoloni E, Priori R, Carubbi F, Corazza L, et al. Anti-SSA/SSB-negative Sjögren’s syndrome shows a lower prevalence of lymphoproliferative manifestations, and a lower risk of lymphoma evolution. Autoimmun Rev. 2015;14(11):1019-1022. doi: 10.1016/j.autrev.2015.07.002Quartuccio L, Baldini C, Bartoloni E, Priori R, Carubbi F, Corazza L, et al. Anti-SSA/SSB-negative Sjögren’s syndrome shows a lower prevalence of lymphoproliferative manifestations, and a lower risk of lymphoma evolution. Autoimmun Rev. 2015;14(11):1019-1022. doi: 10.1016/j.autrev.2015.07.002Torrente-Segarra V, Corominas H, Sánchez-Piedra C, Fernández Castro M, Andreu JL, Martínez-Taboada VM, et al.; SJOGRENSER Study Group of the Spanish Society of Rheumatology. Fibromyalgia prevalence and associated factors in primary Sjögren’s syndrome patients in a large cohort from the Spanish Society of Rheumatology registry (SJOGRENSER). Clin Exp Rheumatol. 2017;35 Suppl 105(3):28-34.Torrente-Segarra V, Corominas H, Sánchez-Piedra C, Fernández Castro M, Andreu JL, Martínez-Taboada VM, et al.; SJOGRENSER Study Group of the Spanish Society of Rheumatology. Fibromyalgia prevalence and associated factors in primary Sjögren’s syndrome patients in a large cohort from the Spanish Society of Rheumatology registry (SJOGRENSER). Clin Exp Rheumatol. 2017;35 Suppl 105(3):28-34.Priori R, Iannuccelli C, Alessandri C, Modesti M, Antonazzo B, Di Lollo AC, et al. Fatigue in Sjogren’s syndrome: Relationship with fibromyalgia, clinical and biologic features. Clin Exp Rheumatol. 2010;28(6 Suppl 63):S82-S86.Priori R, Iannuccelli C, Alessandri C, Modesti M, Antonazzo B, Di Lollo AC, et al. Fatigue in Sjogren’s syndrome: Relationship with fibromyalgia, clinical and biologic features. Clin Exp Rheumatol. 2010;28(6 Suppl 63):S82-S86.Ostuni P, Botsios C, Sfriso P, Punzi L, Chieco-Bianchi F, Semerano L, et al. Fibromyalgia in Italian patients with primary Sjögren’s syndrome. Joint Bone Spine. 2002;69(1):51-57. doi: 10.1016/s1297319x(01)00341-4Ostuni P, Botsios C, Sfriso P, Punzi L, Chieco-Bianchi F, Semerano L, et al. Fibromyalgia in Italian patients with primary Sjögren’s syndrome. Joint Bone Spine. 2002;69(1):51-57. doi: 10.1016/s1297319x(01)00341-4Choi BY, Oh HJ, Lee YJ, Song YW. Prevalence and clinical impact of fibromyalgia in patients with primary Sjögren’s syndrome. Clin Exp Rheumatol. 2016;34(2 Suppl 96):9-13.Choi BY, Oh HJ, Lee YJ, Song YW. Prevalence and clinical impact of fibromyalgia in patients with primary Sjögren’s syndrome. Clin Exp Rheumatol. 2016;34(2 Suppl 96):9-13.Dubost JJ, Couderc M, Pereira B, Mariette X, Seror R, Gottenberg JE, et al. Concomitant fibromyalgia in primary Sjögren’s syndrome in the French ASSESS cohort: Comparison of the ACR 1990 and ACR 2016 criteria, FiRST questionnaire and physician’s opinion. Clin Exp Rheumatol. 2021;39 Suppl 133(6):140-145. doi: 10.55563/clinexprheumatol/uxlsh3Dubost JJ, Couderc M, Pereira B, Mariette X, Seror R, Gottenberg JE, et al. Concomitant fibromyalgia in primary Sjögren’s syndrome in the French ASSESS cohort: Comparison of the ACR 1990 and ACR 2016 criteria, FiRST questionnaire and physician’s opinion. Clin Exp Rheumatol. 2021;39 Suppl 133(6):140-145. doi: 10.55563/clinexprheumatol/uxlsh3Klippel J, Stone J, Crofford L, White P. Primer on the rheumatic diseases. 2008. doi: 10.1007/978-0-387-68566-3Klippel J, Stone J, Crofford L, White P. Primer on the rheumatic diseases. 2008. doi: 10.1007/978-0-387-68566-3Whitcher JP Jr, Gritz DC, Daniels TE. The dry eye: A diagnostic dilemma. Int Ophthalmol Clin. 1998;38(4):23-37. doi: 10.1097/00004397-199803840-00005Whitcher JP Jr, Gritz DC, Daniels TE. The dry eye: A diagnostic dilemma. Int Ophthalmol Clin. 1998;38(4):23-37. doi: 10.1097/00004397-199803840-00005Stankeviciene I, Puriene A, Mieliauskaite D, Stangvaltaite-Mouhat L, Aleksejuniene J. Detection of xerostomia, Sicca, and Sjogren’s syndromes in a national sample of adults. BMC Oral Health. 2021;21(1):552. doi: 10.1186/s12903-021-01917-1Stankeviciene I, Puriene A, Mieliauskaite D, Stangvaltaite-Mouhat L, Aleksejuniene J. Detection of xerostomia, Sicca, and Sjogren’s syndromes in a national sample of adults. BMC Oral Health. 2021;21(1):552. doi: 10.1186/s12903-021-01917-1Legger GE, Erdtsieck MB, de Wolff L, Stel AJ, Los LI, Verstappen GM, et al. Differences in presentation between paediatricand adult-onset primary Sjögren’s syndrome patients. Clin Exp Rheumatol. 2021;39 Suppl 133(6):85-92. doi: 10.55563/clinexprheumatol/vxe6h0Legger GE, Erdtsieck MB, de Wolff L, Stel AJ, Los LI, Verstappen GM, et al. Differences in presentation between paediatricand adult-onset primary Sjögren’s syndrome patients. Clin Exp Rheumatol. 2021;39 Suppl 133(6):85-92. doi: 10.55563/clinexprheumatol/vxe6h0Vasiliev V, Palshina S, Shornicova L, Rodionova E, Novicov A. The course of juvenile onset Sjogren’s syndrome. Clinical and Experimental Rheumatology. 2022:54.Vasiliev V, Palshina S, Shornicova L, Rodionova E, Novicov A. The course of juvenile onset Sjogren’s syndrome. Clinical and Experimental Rheumatology. 2022:54.Daniels TE. Evaluation, differential diagnosis, and treatment of xerostomia. J Rheumatol Suppl. 2000;61:6-10.Daniels TE. Evaluation, differential diagnosis, and treatment of xerostomia. J Rheumatol Suppl. 2000;61:6-10.Brito-Zerón P, Theander E, Baldini C, Seror R, Retamozo S, Quartuccio L, et al.; Eular Sjögren Syndrome Task Force. Early diagnosis of primary Sjögren’s syndrome: EULAR-SS task force clinical recommendations. Expert Rev Clin Immunol. 2016;12(2):137-156. doi: 10.1586/1744666X.2016.1109449Brito-Zerón P, Theander E, Baldini C, Seror R, Retamozo S, Quartuccio L, et al.; Eular Sjögren Syndrome Task Force. Early diagnosis of primary Sjögren’s syndrome: EULAR-SS task force clinical recommendations. Expert Rev Clin Immunol. 2016;12(2):137-156. doi: 10.1586/1744666X.2016.1109449Baldini C, Pepe P, Quartuccio L, Priori R, Bartoloni E, Alunno A, et al. Primary Sjogren’s syndrome as a multi-organ disease: impact of the serological profile on the clinical presentation of the disease in a large cohort of Italian patients. Rheumatology (Oxford). 2014;53(5):839-844. doi: 10.1093/rheumatology/ket427Baldini C, Pepe P, Quartuccio L, Priori R, Bartoloni E, Alunno A, et al. Primary Sjogren’s syndrome as a multi-organ disease: impact of the serological profile on the clinical presentation of the disease in a large cohort of Italian patients. Rheumatology (Oxford). 2014;53(5):839-844. doi: 10.1093/rheumatology/ket427Brito-Zerón P, Izmirly PM, Ramos-Casals M, Buyon JP, Khamashta MA. The clinical spectrum of autoimmune congenital heart block. Nat Rev Rheumatol. 2015;11(5):301-312. doi: 10.1038/nrrheum.2015.29Brito-Zerón P, Izmirly PM, Ramos-Casals M, Buyon JP, Khamashta MA. The clinical spectrum of autoimmune congenital heart block. Nat Rev Rheumatol. 2015;11(5):301-312. doi: 10.1038/nrrheum.2015.29Brito-Zerón P, Pasoto SG, Robles-Marhuenda A, Mandl T, Vissink A, Armagan B, et al.; Sjögren Big Data Consortium. Autoimmune congenital heart block and primary Sjögren’s syndrome: Characterisation and outcomes of 49 cases. Clin Exp Rheumatol. 2020;38 Suppl 126(4):95-102.Brito-Zerón P, Pasoto SG, Robles-Marhuenda A, Mandl T, Vissink A, Armagan B, et al.; Sjögren Big Data Consortium. Autoimmune congenital heart block and primary Sjögren’s syndrome: Characterisation and outcomes of 49 cases. Clin Exp Rheumatol. 2020;38 Suppl 126(4):95-102.Stevens WJ, Swartele FE, Empsten FA, De Clerck LS. Use of the Saxon test as a measure of saliva production in a reference population of schoolchildren. Am J Dis Child. 1990;144(5):570-571. doi: 10.1001/archpedi.1990.02150290064029Stevens WJ, Swartele FE, Empsten FA, De Clerck LS. Use of the Saxon test as a measure of saliva production in a reference population of schoolchildren. Am J Dis Child. 1990;144(5):570-571. doi: 10.1001/archpedi.1990.02150290064029Hershkovich O, Shafat I, Nagler RM. Age-related changes in salivary antioxidant profile: Possible implications for oral cancer. J Gerontol A Biol Sci Med Sci. 2007;62(4):361-366. doi: 10.1093/gerona/62.4.361Hershkovich O, Shafat I, Nagler RM. Age-related changes in salivary antioxidant profile: Possible implications for oral cancer. J Gerontol A Biol Sci Med Sci. 2007;62(4):361-366. doi: 10.1093/gerona/62.4.361Nagler RM. Salivary glands and the aging process: Mechanistic aspects, health-status and medicinal-efficacy monitoring. Biogerontology. 2004;5(4):223-233. doi: 10.1023/B:BGEN.0000038023.36727.50Nagler RM. Salivary glands and the aging process: Mechanistic aspects, health-status and medicinal-efficacy monitoring. Biogerontology. 2004;5(4):223-233. doi: 10.1023/B:BGEN.0000038023.36727.50Fisher BA, Jonsson R, Daniels T, Bombardieri M, Brown RM, Morgan P, et al.; Sjögren’s histopathology workshop group (appendix) from ESSENTIAL (EULAR Sjögren’s syndrome study group). Standardisation of labial salivary gland histopathology in clinical trials in primary Sjögren’s syndrome. Ann Rheum Dis. 2017;76(7):1161-1168. doi: 10.1136/annrheumdis-2016-210448Fisher BA, Jonsson R, Daniels T, Bombardieri M, Brown RM, Morgan P, et al.; Sjögren’s histopathology workshop group (appendix) from ESSENTIAL (EULAR Sjögren’s syndrome study group). Standardisation of labial salivary gland histopathology in clinical trials in primary Sjögren’s syndrome. Ann Rheum Dis. 2017;76(7):1161-1168. doi: 10.1136/annrheumdis-2016-210448Parreau S, Nocturne G, Mariette X, Burroni B, Lazure T, Besson FL, et al. Features of non-Hodgkin’s lymphoma diagnosed in minor salivary gland biopsies from primary Sjögren’s syndrome patients. Rheumatology (Oxford). 2022;61(9):3818-3823. doi: 10.1093/rheumatology/keab949Parreau S, Nocturne G, Mariette X, Burroni B, Lazure T, Besson FL, et al. Features of non-Hodgkin’s lymphoma diagnosed in minor salivary gland biopsies from primary Sjögren’s syndrome patients. Rheumatology (Oxford). 2022;61(9):3818-3823. doi: 10.1093/rheumatology/keab949Раденска-Лоповок СГ, Каранова МС, Занозин АС. Родионова ЕБ, Пальшина СГ, Цветанов МС, и др. Оценка морфологической активности болезни Шёгрена по биоптатам малых слюнных желез. Архив патологии. 2023;85(1):5-9. doi: 10.17116/patol2023850115RadenskaLopovok SG, Karanova MS, Zanozin AS, Zanozin AS, Rodionova EB, Palshina SG, Tsvetanov MS, et al. Evaluation of morphological activity of primary Sjogren’s syndrome on bioptates of minor salivary glands. Russian Journal of Archive of Pathology. 2023;85(1):5-9 (In Russ.). doi: 10.17116/patol2023850115Haacke EA, Bootsma H, Spijkervet FKL, Visser A, Vissink A, Kluin PM, et al. FcRL4+ B-cells in salivary glands of primary Sjögren’s syndrome patients. J Autoimmun. 2017;81:90-98. doi: 10.1016/j.jaut.2017.03.012Haacke EA, Bootsma H, Spijkervet FKL, Visser A, Vissink A, Kluin PM, et al. FcRL4+ B-cells in salivary glands of primary Sjögren’s syndrome patients. J Autoimmun. 2017;81:90-98. doi: 10.1016/j.jaut.2017.03.012Marx RE, Hartman KS, Rethman KV. A prospective study comparing incisional labial to incisional parotid biopsies in the detection and confirmation of sarcoidosis, Sjögren’s disease, sialosis and lymphoma. J Rheumatol. 1988;15(4):621-629.Marx RE, Hartman KS, Rethman KV. A prospective study comparing incisional labial to incisional parotid biopsies in the detection and confirmation of sarcoidosis, Sjögren’s disease, sialosis and lymphoma. J Rheumatol. 1988;15(4):621-629.Васильев ВИ, Пробатова НА, Тупицын НН, Варламова ЕЮ, Логвиненко ОА, Ковригина АМ, и др. Лимфопролиферативные заболевания при болезни Шёгрена. Онкогематология. 2007;2(3):16-26. doi: 10.17650/1818-83462007-0-3-16-26Vasiljev VI, Probatova NA, Tupitsyn NN, Varlamova EY, Logvinenko OA, Kovrigina AM, et al. Lymphoproliferative diseases in primary Sjogren’s syndrome. Oncohematology. 2007;(3):16-26 (In Russ.). doi: 10.17650/1818-83462007-0-3-16-26Васильев ВИ, Логвиненко ОА, Пробатова НА, Кокосадзе НВ, Городецкий ВР, Ковригина АМ, и др. Роль биопсии околоушной слюнной железы в ранней диагностике лимфом при болезни Шёгрена. Терапевтический архив. 2009;81(6):2026.Vasil’ev VI, Logvinenko OA, Probatova NA, Kokosadze NV, Gorodetskiy VR, Kovrigina AM, et al. The role of parotid gland biopsy in early detection of lymphoma in primary Sjogren’s syndrome. Terapevticheskii arkhiv . 2009;81(6):20-26 (In Russ.).Pijpe J, Kalk WW, van der Wal JE, Vissink A, Kluin PM, Roodenburg JL, et al. Parotid gland biopsy compared with labial biopsy in the diagnosis of patients with primary Sjogren’s syndrome. Rheumatology (Oxford). 2007;46(2):335-341. doi: 10.1093/rheumatology/kel266Pijpe J, Kalk WW, van der Wal JE, Vissink A, Kluin PM, Roodenburg JL, et al. Parotid gland biopsy compared with labial biopsy in the diagnosis of patients with primary Sjogren’s syndrome. Rheumatology (Oxford). 2007;46(2):335-341. doi: 10.1093/rheumatology/kel266Spijkervet FK, Haacke E, Kroese FG, Bootsma H, Vissink A. Parotid gland biopsy, the alternative way to diagnose sjögren syndrome. Rheum Dis Clin North Am. 2016;42(3):485-499. doi: 10.1016/j.rdc.2016.03.007Spijkervet FK, Haacke E, Kroese FG, Bootsma H, Vissink A. Parotid gland biopsy, the alternative way to diagnose sjögren syndrome. Rheum Dis Clin North Am. 2016;42(3):485-499. doi: 10.1016/j.rdc.2016.03.007Clark M, Walsh H, Stephens-Laborde I, Khurram SA. The value of labial gland biopsies as a diagnostic test for Sjögren’s syndrome. Head Neck Pathol. 2024;18(1):64. doi: 10.1007/s12105024-01662-1Clark M, Walsh H, Stephens-Laborde I, Khurram SA. The value of labial gland biopsies as a diagnostic test for Sjögren’s syndrome. Head Neck Pathol. 2024;18(1):64. doi: 10.1007/s12105024-01662-1Risselada AP, Kruize AA, Goldschmeding R, Lafeber FP, Bijlsma JW, van Roon JA. The prognostic value of routinely performed minor salivary gland assessments in primary Sjögren’s syndrome. Ann Rheum Dis. 2014;73(8):1537-1540. doi: 10.1136/annrheumdis-2013-204634Risselada AP, Kruize AA, Goldschmeding R, Lafeber FP, Bijlsma JW, van Roon JA. The prognostic value of routinely performed minor salivary gland assessments in primary Sjögren’s syndrome. Ann Rheum Dis. 2014;73(8):1537-1540. doi: 10.1136/annrheumdis-2013-204634Bodeutsch C, de Wilde PC, Kater L, van den Hoogen FH, Hené RJ, van Houwelingen JC, et al. Monotypic plasma cells in labial salivary glands of patients with Sjögren’s syndrome: Prognosticator for systemic lymphoproliferative disease. J Clin Pathol. 1993;46(2):123-128. doi: 10.1136/jcp.46.2.123Bodeutsch C, de Wilde PC, Kater L, van den Hoogen FH, Hené RJ, van Houwelingen JC, et al. Monotypic plasma cells in labial salivary glands of patients with Sjögren’s syndrome: Prognosticator for systemic lymphoproliferative disease. J Clin Pathol. 1993;46(2):123-128. doi: 10.1136/jcp.46.2.123Theander E, Vasaitis L, Baecklund E, Nordmark G, Warfvinge G, Liedholm R, et al. Lymphoid organisation in labial salivary gland biopsies is a possible predictor for the development of malignant lymphoma in primary Sjögren’s syndrome. Ann Rheum Dis. 2011;70(8):1363-1368. doi: 10.1136/ard.2010.144782Theander E, Vasaitis L, Baecklund E, Nordmark G, Warfvinge G, Liedholm R, et al. Lymphoid organisation in labial salivary gland biopsies is a possible predictor for the development of malignant lymphoma in primary Sjögren’s syndrome. Ann Rheum Dis. 2011;70(8):1363-1368. doi: 10.1136/ard.2010.144782Родионова ЕБ, Васильев ВИ, Прокопенко ВД, Логвиненко ОА. Антиген-представляющие клетки лимфогистиоцитарного инфильтрата при болезни Шегрена. Научно-практическая ревматология. 2006;3:16-19.Rodionova EB, Vasil’ev VI, Prokopenko VD, Logvinenko OA. Antigen-presenting cells of the lymphohistiocytic infiltrate in Sjögren’s disease. NauchnoPrakticheskaya Revmatologia = Rheumatology Science and Practice. 2006;3:16-19 (In Russ.).Paschides CA, Kitsios G, Karakostas KX, Psillas C, Moutsopoulos HM. Evaluation of tear break-up time, Schirmer’s-I test and rose bengal staining as confirmatory tests for keratoconjunctivitis sicca. Clin Exp Rheumatol. 1989;7(2):155-157.Paschides CA, Kitsios G, Karakostas KX, Psillas C, Moutsopoulos HM. Evaluation of tear break-up time, Schirmer’s-I test and rose bengal staining as confirmatory tests for keratoconjunctivitis sicca. Clin Exp Rheumatol. 1989;7(2):155-157.Whitcher JP, Shiboski CH, Shiboski SC, Heidenreich AM, Kitagawa K, Zhang S, et al.; Sjögren’s International Collaborative Clinical Alliance Research Groups. A simplified quantitative method for assessing keratoconjunctivitis sicca from the Sjögren’s Syndrome International Registry. Am J Ophthalmol. 2010;149(3):405-415. doi: 10.1016/j.ajo.2009.09.013Whitcher JP, Shiboski CH, Shiboski SC, Heidenreich AM, Kitagawa K, Zhang S, et al.; Sjögren’s International Collaborative Clinical Alliance Research Groups. A simplified quantitative method for assessing keratoconjunctivitis sicca from the Sjögren’s Syndrome International Registry. Am J Ophthalmol. 2010;149(3):405-415. doi: 10.1016/j.ajo.2009.09.013Wang B, Chen S, Zheng Q, Li Y, Zhang X, Xuan J, et al. Early diagnosis and treatment for Sjögren’s syndrome: Current challenges, redefined disease stages and future prospects. J Autoimmun. 2021;117:102590. doi: 10.1016/j.jaut.2020.102590Wang B, Chen S, Zheng Q, Li Y, Zhang X, Xuan J, et al. Early diagnosis and treatment for Sjögren’s syndrome: Current challenges, redefined disease stages and future prospects. J Autoimmun. 2021;117:102590. doi: 10.1016/j.jaut.2020.102590Васильев ВИ, Логвиненко ОА, Симонова МВ, Сафонова ТН, Раденска-Лоповок СГ, Божьева ЛА, и др. Развитие сухого синдрома при саркоидозе с поражением слюнных и слезных желез. Терапевтический архив. 2005;77(1):62-67Vasil’ev VI, Logvinenko OA, Simonova MV, Safonova TN, Radenska-Lopovok SG, Bozhieva LA, et al. Auricular syndrome in sarcoidosis and involvement of the salivary and lacrymal glands. Terapevticheskii arkhiv. 2005;77(1):62-67 (In Russ.).Mathew R, Zeppieri M. Ocular amyloidosis. Treasure Island (FL): StatPearls Publishing; 2024.Mathew R, Zeppieri M. Ocular amyloidosis. Treasure Island (FL): StatPearls Publishing; 2024.Schonberg S, Stokkermans TJ. Ocular pemphigoid. Treasure Island (FL):StatPearls Publishing; 2023.Schonberg S, Stokkermans TJ. Ocular pemphigoid. Treasure Island (FL):StatPearls Publishing; 2023.Golden MI, Meyer JJ, Zeppieri M, Patel BC. Dry eye syndrome. Treasure Island (FL):StatPearls Publishing; 2024.Golden MI, Meyer JJ, Zeppieri M, Patel BC. Dry eye syndrome. Treasure Island (FL):StatPearls Publishing; 2024.Bjerrum KB. Keratoconjunctivitis sicca and primary Sjögren’s syndrome in a Danish population aged 30–60 years. Acta Ophthalmol Scand. 1997;75(3):281-286. doi: 10.1111/j.1600-0420.1997.tb00774.xBjerrum KB. Keratoconjunctivitis sicca and primary Sjögren’s syndrome in a Danish population aged 30–60 years. Acta Ophthalmol Scand. 1997;75(3):281-286. doi: 10.1111/j.1600-0420.1997.tb00774.xForstot JZ, Forstot SL, Greer RO, Tan EM. The incidence of Sjögren’s sicca complex in a population of patients with keratoconjunctivitis sicca. Arthritis Rheum. 1982;25(2):156-160. doi: 10.1002/art.1780250207Forstot JZ, Forstot SL, Greer RO, Tan EM. The incidence of Sjögren’s sicca complex in a population of patients with keratoconjunctivitis sicca. Arthritis Rheum. 1982;25(2):156-160. doi: 10.1002/art.1780250207Kruize AA, Hené RJ, van der Heide A, Bodeutsch C, de Wilde PC, van Bijsterveld OP, et al. Long-term followup of patients with Sjögren’s syndrome. Arthritis Rheum. 1996;39(2):297-303. doi: 10.1002/art.1780390219Kruize AA, Hené RJ, van der Heide A, Bodeutsch C, de Wilde PC, van Bijsterveld OP, et al. Long-term followup of patients with Sjögren’s syndrome. Arthritis Rheum. 1996;39(2):297-303. doi: 10.1002/art.1780390219Kruize AA, van Bijsterveld OP, Hené RJ, de Wilde PC, Feltkamp TE, Kater L, et al. Long-term course of tear gland function in patients with keratoconjunctivitis sicca and Sjögren’s syndrome. Br J Ophthalmol. 1997;81(6):435-438. doi: 10.1136/bjo.81.6.435Kruize AA, van Bijsterveld OP, Hené RJ, de Wilde PC, Feltkamp TE, Kater L, et al. Long-term course of tear gland function in patients with keratoconjunctivitis sicca and Sjögren’s syndrome. Br J Ophthalmol. 1997;81(6):435-438. doi: 10.1136/bjo.81.6.435Ramsubeik K, Motilal S, Sanchez-Ramos L, Ramrattan LA, Kaeley GS, Singh JA. Diagnostic accuracy of salivary gland ultrasound in Sjögren’s syndrome: A systematic review and meta-analysis. Ther Adv Musculoskelet Dis. 2020;12:1759720X20973560. doi: 10.1177/1759720X20973560Ramsubeik K, Motilal S, Sanchez-Ramos L, Ramrattan LA, Kaeley GS, Singh JA. Diagnostic accuracy of salivary gland ultrasound in Sjögren’s syndrome: A systematic review and meta-analysis. Ther Adv Musculoskelet Dis. 2020;12:1759720X20973560. doi: 10.1177/1759720X20973560Narayan AK, Baer A, Fradin J. Sonographic findings of IgG4related disease of the salivary glands: Case report and review of the literature. J Clin Ultrasound. 2018;46(1):73-77. doi: 10.1002/jcu.22482Narayan AK, Baer A, Fradin J. Sonographic findings of IgG4related disease of the salivary glands: Case report and review of the literature. J Clin Ultrasound. 2018;46(1):73-77. doi: 10.1002/jcu.22482Lorenzon M, Tulipano Di Franco F, Zabotti A, Pegolo E, Giovannini I, Manfrè V, et al. Sonographic features of lymphoma of the major salivary glands diagnosed with ultrasound-guided core needle biopsy in Sjögren’s syndrome. Clin Exp Rheumatol. 2021;39 Suppl 133(6):175-183. doi: 10.55563/clinexprheumatol/4c36nrLorenzon M, Tulipano Di Franco F, Zabotti A, Pegolo E, Giovannini I, Manfrè V, et al. Sonographic features of lymphoma of the major salivary glands diagnosed with ultrasound-guided core needle biopsy in Sjögren’s syndrome. Clin Exp Rheumatol. 2021;39 Suppl 133(6):175-183. doi: 10.55563/clinexprheumatol/4c36nrOrita Y, Sato Y, Kimura N, Marunaka H, Tachibana T, Yamashita Y, et al. Characteristic ultrasound features of mucosa-associated lymphoid tissue lymphoma of the salivary and thyroid gland. Acta Otolaryngol. 2014;134(1):93-99. doi: 10.3109/00016489.2013.831994Orita Y, Sato Y, Kimura N, Marunaka H, Tachibana T, Yamashita Y, et al. Characteristic ultrasound features of mucosa-associated lymphoid tissue lymphoma of the salivary and thyroid gland. Acta Otolaryngol. 2014;134(1):93-99. doi: 10.3109/00016489.2013.831994

The authors declare that there are no conflicts of interest present.